Natco Pharma Ltd.

Natco Pharma has received Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its drug formulations manufacturing facility at Visakhapatnam (Vizag), Andhra Pradesh, India. Earlier, USFDA had conducted inspection at the said manufacturing facility from January 30, 2023 to February 03, 2023.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.